Nature's Sunshine Products Inc. has announced a share purchase agreement to acquire Fosun Industrial's interests in two joint ventures in China. This follows Fosun Pharma's sale of 2,854,607 shares, reducing its stake below 5% in Nature's Sunshine. The company will purchase Fosun's 20% interest in the Hong Kong Joint Venture for $3.9 million and the Shanghai Joint Venture for $3.1 million. The transactions are subject to regulatory approvals in China.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nature's Sunshine Products Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-25-034416), on July 07, 2025, and is solely responsible for the information contained therein.